About the Authors

Sona Kang, Peter Akerblad, Michael J. Griffin, Jie Min, Evan D. Rosen
Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

Sona Kang, Peter Akerblad, Rana K. Gupta, Shingo Kajimura, Michael J. Griffin, Jie Min, Evan D. Rosen
Harvard Medical School, Boston, Massachusetts, United States of America

Peter Akerblad
AstraZeneca R&D Mölndal, Mölndal, Sweden

Riku Kiviranta, Roland Baron
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, and Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America

Rana K. Gupta, Shingo Kajimura
Department of Cancer Biology and Division of Metabolism and Chronic Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

Corresponding Author

erosen@bidmc.harvard.edu

Competing Interests

One author (PA) is employed by a commercial entity (AstraZeneca), but there are no restrictions put by this company to publish this work or make data or materials available.

Author Contributions

The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: SoK EDR RB RK ShK RG MG PA. Performed the experiments: SoK RK MG JM. Analyzed the data: SoK RK EDR RB. Contributed reagents/materials/analysis tools: RK RB MG. Wrote the paper: EDR SoK.